Scientists from the National Institutes of Health reported that a single dose of an experimental Ebola vaccine protects macaques within seven days of infection.
Robust CD8+ memory T cells are important for protection against severe influenza disease caused by newly emerging strains.
Clinical trial results for pancreatic cancer vaccines GVAX and CRS-207 demonstrate an improved outcome for patients, resulting from cancer-fighting T cells.
B cells orchestrate mutations on cue. The procedure for antibody development requires a second take to get the performance right.